Document is current
Any future updates will be listed below
-
Authors
Tran, Nguyen H
Foster, Nathan R
Mahipal, Amit
Byrne, Thomas
Hubbard, Joleen
Silva, Alvin
Mody, Kabir
Alberts, Steven
Borad, Mitesh J.
-
Funding
Funding for this research was provided by:
National Cancer Institute (CA090628)
Threshold Pharmaceuticals
National Institutes of Health (U10CA180821)
National Institutes of Health (U10CA180882)
National Institutes of Health (UG1CA232760)
- License Information
-
More Information
Article History
Received: 18 February 2021
Accepted: 22 February 2021
First Online: 1 March 2021
Declarations
:
: none.
: not applicable.
: The study protocol was approved by the institutional review board at each study site. All patients signed an IRB-approved, protocol-specific written informed consent document in accordance with federal and institutional guidelines.
: not applicable.
